myeloma precursor disease multiple myeloma diagnostic concepts opportunities early intervention pubmed ncbi abstract monoclonal gammopathy undetermined significance mgus num years ago definition entity evolved today num distinct clinical mgus subtypes defined non-immunoglobulin igm igg iga mgus igm mgus light chain mgus clinical mgus subtype characterized unique intermediate stages progression events strong evidence multiple myeloma consistently preceded precursor state molecular level urgent understand mechanisms regulate transformation precursor full-blown multiple myeloma future knowledge clinicians define high-risk low-risk precursor patients tailored clinical management provide insights individual patient's disease biology turn targeted individualized treatment strategies basis current clinical guidelines patients diagnosed mgus smoldering myeloma treated clinical trials future reasonable high-risk precursor patients candidates early treatment strategies review discuss insights recent studies propose future directions relevance clinical management research studies num aacr 
